As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe disease and evade vaccine-induced immunity is rapidly assessed in humans and studied in animal models. In early January 2021, a novel SARS-CoV-2 variant designated B.1.429 comprising 2 lineages, B.1.427 and B.1.429, was originally detected in California (CA) and it was shown to have enhanced infectivity in vitro and decreased antibody neutralization by plasma from convalescent patients and vaccine recipients. Here we examine the virulence, transmissibility, and susceptibility to pre-existing immunity for B 1.427 and B 1.429 in the Syrian hamster model. We find that both variants exhibit enhanced virulence as measured by increased body weight loss compared to hamsters infected with ancestral B.1 (614G), with B.1.429 causing the most marked body weight loss among the 3 variants. Faster dissemination from airways to parenchyma and more severe lung pathology at both early and late stages were also observed with B.1.429 infections relative to B.1. (614G) and B.1.427 infections. In addition, subgenomic viral RNA (sgRNA) levels were highest in oral swabs of hamsters infected with B.1.429, however sgRNA levels in lungs were similar in all three variants. This demonstrates that B.1.429 replicates to higher levels than ancestral B.1 (614G) or B.1.427 in the oropharynx but not in the lungs. In multi-virus in-vivo competition experiments, we found that B.1. (614G), epsilon (B.1.427/B.1.429) and gamma (P.1) dramatically outcompete alpha (B.1.1.7), beta (B.1.351) and zeta (P.2) in the lungs. In the nasal cavity, B.1. (614G), gamma, and epsilon dominate, but the highly infectious alpha variant also maintains a moderate size niche. We did not observe significant differences in airborne transmission efficiency among the B.1.427, B.1.429 and ancestral B.1 (614G) and WA-1 variants in hamsters. These results demonstrate enhanced virulence and high relative oropharyngeal replication of the epsilon (B.1.427/B.1.429) variant in Syrian hamsters compared to an ancestral B.1 (614G) variant. Author summary In 2020 and 2021, new variants of SARS-CoV-2 were detected in the UK, South Africa, Brazil, India, California and beyond. New SARS-CoV-2 variants will continue to emerge for the foreseeable future in the human population and the potential for these new variants to produce severe disease and evade vaccines needs to be understood. In this study, we used the hamster model to determine the epsilon (B.1.427/429) SARS-CoV-2 variants that emerged in California in late 2020 cause more severe disease and infected hamsters have higher viral RNA levels in oral swabs compared to the prior B.1 (614G) variant. These findings are consistent with human clinical data and help explain the emergence and rapid spread of this variant in early 2021.
【초록키워드】 Brazil, Vaccine, hamsters, B.1.351, body weight, susceptibility, Human, India, variant, SARS-CoV-2 variant, Infection, lung, Transmission, nasal, animal models, in vitro, variants, airway, Replication, Spread, Convalescent patients, South Africa, infections, Viral, Transmissibility, SARS-CoV-2 variants, B.1.427, B.1.1.7, P.1, Epsilon, Lungs, sgRNA, Alpha, B.1.429, P.2, plasma, Beta, Viral RNA, Oropharyngeal, hamster, dissemination, Nasal cavity, virulence, lineages, Critical, moderate, pre-existing immunity, Antibody neutralization, convalescent patient, severe disease, B.1, Vaccine-induced immunity, Efficiency, airways, human population, weight loss, significant difference, significant differences, recipients, Clinical data, help, Zeta, late stage, oral swab, oral swabs, oropharynx, Body weight loss, parenchyma, variants of SARS-CoV-2, severe lung pathology, observé, highest, shown, addition, replicate, determine, maintain, evade, explain, experiments, New, 【제목키워드】 hamster, B.1, virulent,